Interleukin 6 and/or Interleukin 17A Modulate the OPG/RANKL System of MC3T3-E1 Murine Osteoblast Cell Line

No abstract is available for this paper.

• Publication year

  2016

• Venue

  International Journal of Peptide Research and Therapeutics

• Publication date

  2016-05-14

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/s10989-016-9529-5
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The Effects of Immune Cell Products (Cytokines and Hematopoietic Cell Growth Factors) on Bone Cells

  2016cited by this paper
• IL-6 negatively regulates osteoblast differentiation through the SHP2/MEK2 and SHP2/Akt2 pathways in vitro

  2014cited by this paper
• Effects of Interleukin-17A on Osteogenic Differentiation of Isolated Human Mesenchymal Stem Cells

  2014cited by this paper
• Chapter 2 – Bone Cells

  2014cited by this paper
• IL-17 inhibits osteoblast differentiation and bone regeneration in rat.

  2014cited by this paper
• Protective effect of zinc supplementation against cadmium-induced oxidative stress and the RANK/RANKL/OPG system imbalance in the bone tissue of rats.

  2013cited by this paper
• Role of local vitamin D signaling and cellular calcium transport system in bone homeostasis

  2013cited by this paper
• Mendelian Disorders of RANKL/OPG/RANK Signaling

  2013cited by this paper
• Adipocyte-secreted factors increase osteoblast proliferation and the OPG/RANKL ratio to influence osteoclast formation.

  2012cited by this paper
• Induction of Osteogenesis in Mesenchymal Stem Cells by Activated Monocytes/Macrophages Depends on Oncostatin M Signaling

  2012cited by this paper
• T-Lymphocytes Enable Osteoblast Maturation via IL-17F during the Early Phase of Fracture Repair

  2012cited by this paper
• IL-32 and IL-17 interact and have the potential to aggravate osteoclastogenesis in rheumatoid arthritis

  2012cited by this paper
• The IL6 gene polymorphism -634C>G and IL17F gene polymorphism 7488T>C influence bone mineral density in young and elderly Japanese women.

  2012cited by this paper
• Strontium signaling: molecular mechanisms and therapeutic implications in osteoporosis.

  2012cited by this paper
• Insights into the regulation of protein abundance from proteomic and transcriptomic analyses

  2012cited by this paper
• Prominent Bone Loss Mediated by RANKL and IL-17 Produced by CD4+ T Cells in TallyHo/JngJ Mice

  2011cited by this paper
• Osteoprotegerin (OPG) and Related Proteins (RANK, RANKL and TRAIL) in Thyroid Disease

  2011cited by this paper
• The Roles of Interleukin-6 in the Pathogenesis of Rheumatoid Arthritis

  2011cited by this paper
• Biological factors responsible for failure of osseointegration in oral implants

  2011cited by this paper
• Role of RANK, RANKL, OPG, and CXCR4 tissue markers in predicting bone metastases in breast cancer patients.

  2011cited by this paper
• The response of T cells to interleukin-6 is differentially regulated by the microenvironment of the rheumatoid synovial fluid and tissue.

  2011cited by this paper
• The pro- and anti-inflammatory properties of the cytokine interleukin-6.

  2011cited by this paper
• Early predictors of increased bone resorption in juvenile idiopathic arthritis: OPG/RANKL ratio, as a key regulator of bone metabolism

  2011cited by this paper
• 7 – The Effects of Immune Cell Products (Cytokines and Hematopoietic Cell Growth Factors) on Bone Cells

  2011cited by this paper
• Global quantification of mammalian gene expression control

  2011cited by this paper
• Local microbleeding facilitates IL-6– and IL-17–dependent arthritis in the absence of tissue antigen recognition by activated T cells

  2011cited by this paper
• Cellular and Molecular Mechanisms of Bone Remodeling*

  2010cited by this paper
• Theoretical investigation of the role of the RANK-RANKL-OPG system in bone remodeling.

  2010cited by this paper
• A bone‐protective role for IL‐17 receptor signaling in ovariectomy‐induced bone loss

  2009cited by this paper
• Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo.

  2009cited by this paper
• RANKL/OPG in primary cultures of osteoblasts from post-menopausal women. Differences between osteoporotic hip fractures and osteoarthritis.

  2009cited by this paper
• Gene expressions of Collagen type I, ALP and BMP-4 in osteo-inductive BCP implants show similar pattern to that of natural healing bones

  2009cited by this paper
• IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling

  2009cited by this paper
• Interleukin-6 Directly Inhibits Osteoclast Differentiation by Suppressing Receptor Activator of NF-κB Signaling Pathways*

  2008cited by this paper
• Local Regulators of Bone: IL-1, TNF, Lymphotoxin, Interferon-γ, the LIF/IL-6 Family, and Additional Cytokines

  2008cited by this paper
• Molecular Mechanisms Controlling Bone Formation during Fracture Healing and Distraction Osteogenesis

  2008cited by this paper
• IL-6 Induces Osteoblastic Differentiation of Periodontal Ligament Cells

  2008cited by this paper
• Activation of the receptor EphB4 by its specific ligand ephrin B2 in human osteoarthritic subchondral bone osteoblasts.

  2008cited by this paper
• High levels of synovial fluid osteoprotegerin (OPG) and increased serum ratio of receptor activator of nuclear factor-kappa B ligand (RANKL) to OPG correlate with disease severity in patients with primary knee osteoarthritis.

  2008cited by this paper
• Interleukin-6 inhibits receptor activator of nuclear factor kappaB ligand-induced osteoclastogenesis by diverting cells into the macrophage lineage: key role of Serine727 phosphorylation of signal transducer and activator of transcription 3.

  2008cited by this paper
• IL-6 receptor expression and IL-6 effects change during osteoblast differentiation.

  2008cited by this paper
• Kinetics of RANKL, RANK and OPG expressions in experimentally induced rat periapical lesions.

  2007cited by this paper
• Differential expression of RANK, RANK-L, and osteoprotegerin by synovial fluid neutrophils from patients with rheumatoid arthritis and by healthy human blood neutrophils

  2007cited by this paper
• RANKL-RANK signaling in osteoclastogenesis and bone disease.

  2006cited by this paper
• A critical role for interleukin-6 family-mediated Stat3 activation in osteoblast differentiation and bone formation.

  2006cited by this paper
• An in vitro comparison of implant materials cell attachment, cytokine and osteocalcin production.

  2005cited by this paper
• Osteoprotegerin (OPG) and RANKL expression and distribution in developing human craniomandibular joint.

  2005cited by this paper
• The role of markers of bone remodeling in multiple myeloma.

  2005cited by this paper
• Interleukin-6: An osteotropic factor influencing bone formation?

  2005cited by this paper
• Current concepts of molecular aspects of bone healing.

  2005cited by this paper
• Cytokines link osteoblasts and inflammation: microarray analysis of interleukin‐17‐ and TNF‐α‐induced genes in bone cells

  2005cited by this paper
• Interleukin (IL)‐17 enhances tumor necrosis factor‐α‐stimulated IL‐6 synthesis via p38 mitogen‐activated protein kinase in osteoblasts

  2004cited by this paper
• Interleukin-17: a mediator of inflammatory responses

  2004cited by this paper
• The OPG/RANKL/RANK system in metabolic bone diseases.

  2004cited by this paper
• The effect of the physical characteristics of hydroxyapatite particles on human monocytes IL-18 production in vitro.

  2004cited by this paper
• Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls.

  2003cited by this paper
• Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency.

  2002cited by this paper
• IL-6, Leukemia Inhibitory Factor, and Oncostatin M Stimulate Bone Resorption and Regulate the Expression of Receptor Activator of NF-κB Ligand, Osteoprotegerin, and Receptor Activator of NF-κB in Mouse Calvariae1

  2002cited by this paper
• Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism.

  2002cited by this paper
• Role of RANKL and RANK in bone loss and arthritis

  2002cited by this paper
• Differential Temporal Expression of Members of the Transforming Growth Factor β Superfamily During Murine Fracture Healing

  2002cited by this paper
• Interleukin (IL)-17 enhances prostaglandin F(2 alpha)-stimulated IL-6 synthesis in osteoblasts.

  2002cited by this paper
• Local Regulators of Bone: IL-1, TNF, Lymphotoxin, Interferon-γ, IL-8, IL-10, IL-4, the LIF/IL-6 Family, and Additional Cytokines

  2002cited by this paper
• Interleukin (IL)-13 and IL-4 inhibit proliferation and stimulate IL-6 formation in human osteoblasts: evidence for involvement of receptor subunits IL-13R, IL-13Ralpha, and IL-4Ralpha.

  2001cited by this paper
• Expression of Osteoprotegerin, Receptor Activator of NF‐κB Ligand (Osteoprotegerin Ligand) and Related Proinflammatory Cytokines During Fracture Healing

  2001cited by this paper
• The mechanisms of estrogen regulation of bone resorption.

  2000cited by this paper
• Measurement of Cytokine Secretion, Intracellular Protein Expression, and mRNA in Resting and Stimulated Peripheral Blood Mononuclear Cells

  2000cited by this paper
• Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.

  2000cited by this paper
• STAT3 Activation in Stromal/Osteoblastic Cells Is Required for Induction of the Receptor Activator of NF-κB Ligand and Stimulation of Osteoclastogenesis by gp130-utilizing Cytokines or Interleukin-1 but Not 1,25-Dihydroxyvitamin D3 or Parathyroid Hormone*

  1999cited by this paper
• Combination of Interleukin‐6 and Soluble Interleukin‐6 Receptors Induces Differentiation and Activation of JAK‐STAT and MAP Kinase Pathways in MG‐63 Human Osteoblastic Cells

  1998cited by this paper
• Interleukin-6-type cytokines stimulate mesenchymal progenitor differentiation toward the osteoblastic lineage.

  1998cited by this paper
• Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis.

  1995cited by this paper
• Alkaline phosphatase and bone calcium parameters.

  1986cited by this paper

• Interleukin‐17A promotes osteogenic differentiation by increasing OPG/RANKL ratio in stem cells from human exfoliated deciduous teeth (SHED)

  2018cites this paper
• The synergistic effects of IL-6/IL-17A promote osteogenic differentiation by improving OPG/RANKL ratio and adhesion of MC3T3-E1 cells on hydroxyapatite.

  2018cites this paper
• Injectable strontium-doped hydroxyapatite integrated with phosphoserine-tethered poly(epsilon-lysine) dendrons for osteoporotic bone defect repair.

  2018cites this paper